GLYNN CRAIG (Chief Financial Officer) received a stock award from ENVVENO MEDICAL CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/2/2021ACC: 0001493152-21-030331
Officer· Chief Financial Officer
Since Apr 2020
+175.93K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
175.93K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
New position
11/30/2021
0.00→50K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2021 | A · Award | +50K | — | — | New position | 0.00 | 50K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Stock Options
Direct
Converts to
Common Stock
125.92K shares
Shares
+125.92K
Strike price
6.70
Held after
125.92K
Exercisable
—
11/30/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock125.92K shares | 11/30/2021 | A · Award | +125.92K | 6.70 | — | 125.92K |